Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
0 hedge funds and large institutions have $0 invested in Cantel Medical Corporation in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 234 closing their positions.
100% less funds holding
Funds holding: 234 → 0 (-234)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $3.05B → $0 (-$3.05B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 234
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$388M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$320M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$246M |
| 4 |
JP Morgan Chase
New York
|
-$149M |
| 5 |
LGP
Leonard Green & Partners
Los Angeles,
California
|
-$120M |
CMD Hedge Fund Activity: Q2 2021 in Review
0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q2 2021, worth a combined $0 — down 100% from $3.05B a quarter earlier.
Sellers outnumbered buyers: 234 funds closed out of CMD and 0 opened new positions — a net loss of 234 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $388M sold.
- 0 institutional investors held Cantel Medical Corporation (CMD) as of Q2 2021, down from 234 in Q1 2021.
- Funds reported $0 of Cantel Medical Corporation stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new Cantel Medical Corporation positions in Q2 2021 and 234 closed out, a net change of -234 holders.
- The largest Cantel Medical Corporation seller in Q2 2021 was BlackRock, an estimated $388M sold.
Based on aggregated 13F filings for Q2 2021.